baber/WOPTO huggingface dataset:
Patent CA-2666661-A1 (CA)
Inventor: MICHEL RAPHAEL M
IPC: A61B18/04
Filed: 2007-10-18
Abstract: A catheter and catheter system can use energy tailored for remodeling and/or removal of target material along a body lumen, often of atherosclerotic material of a blood vessel of a patient. An elongate flexible catheter body with a radially expandable structure may have a plurality of electrodes or other electrosurgical energy delivery surfaces to radially engage atherosclerotic material when the structure expands. An atherosclerotic material detector system may measure and/or characterize the atherosclerotic material and its location, optionally using impedance monitoring.
Patent CA-2668723-A1 (CA)
Inventor: GEORGE PAUL E
IPC: H01M8/04
Filed: 2007-11-05
Abstract: A method and apparatus for improving the water balance in a power unit by providing the exhaust gas from the cathode side of the fuel cell as a feed gas to the combustion system, condensing at least a portion of water present in the effluent from the combustion system in a condenser, and then transferring water vapor from the uncondensed portion of the effluent from the condenser to the gas fed to the cathode side of the fuel cell. Water from the exhaust gas from the cathode side of the fuel cell is either captured in the condenser, or is reused in the feed gas of the cathode side of the fuel cell. By humidifying the air fed into system with the water vapor present in the exhaust gas, water is not lost from the system. Instead, the air is being fed into the system is humidified with this water, which in turn allows the humidifier to operated at higher temperatures and/or use smaller radiators and fans and/or draw less parasitic power, thereby increasing overall system efficiency.
Patent CA-2669229-A1 (CA)
Inventor: PIERCE DAVID MONTAGUE
IPC: A61K31/192
Filed: 2007-09-27
Abstract: The present invention provides methods of treating inflammatory bowel disease comprising administering to a subject in which remission has not been achieved after a first treatment of about 4-8 weeks of 5-ASA (mesalamine or 5-ASA), a further daily dose greater than about 4 g of 5-ASA in controlled release form to achieve a favorable response to treatment.
Patent CA-2671439-A1 (CA)
Inventor: DELCOUR JAN
IPC: A21D8/04
Filed: 2008-01-16
Abstract: The present invention relates to a method for increasing in a baked product, after baking, the level of water-soluble arabinoxylan with an average degree of polymerization ranging from 5 to 50, preferably ranging from 5 to 35, more preferably ranging from 5 to 25, said method comprising the steps of : - Preparing a dough for a baked product with flour, a mixture of flours or a mixture of flour (s) with milling fractions having a total arabinoxylan content of at least 2.0%, preferably at least 2.5%, and - Adding to said dough an enzyme preparation comprising at least one thermophilic endoxylanase in an amount at least 2-fold higher, preferably at least 3 to 6 times higher or even 10 times higher than the dose conferring 90% of the maximal bread volume increase obtained by addition of such enzyme preparation to the recipe of said baked product. Advantageously with said method baked products can be obtained that have a level of arabinoxylan of the desired type of at least 1.7%, more preferably at least 1.75%, such as at least 1.8%, 1.9% or 2.0%. The present invention further relates to baked products obtainable by this method, and to an improver and a dough which may be used for the preparation of such products. Baked products according to the invention advantageously have improved health benefits.
Patent CA-2672112-A1 (CA)
Title: Method for making chlorinated polyolefin solutions and coatings
Inventor: MENOVCIK GREGORY G
IPC: C08J3/09
Filed: 2007-10-30
Abstract: A method of making an organic solution of a chlorinated polyolefin that produces a storage-stable solution, a chlorinated polyolefin resin is dissolved in a hydrocarbon solvent that is predominantly aliphatic hydrocarbon, aromatic hydrocarbons other than toluene and xylene, or mixtures of these, held at a temperature from 118 to 125 C, for an adequate time for complete dissolution, then cooled and a cosolvent is added at a temperature below the boiling point of the cosolvent but at a temperature at which the chlorinated polyolefin solution is still clear or has little haziness. The solution can be used to prepare coatings, primers, inks, and adhesives, particularly for plastic substrates such as thermoplastic polyolefin.
Patent CA-2672973-A1 (CA)
Inventor: CANDILLON PASCAL
IPC: A61K47/10
Filed: 2007-12-21
Abstract: The present invention relates to new processes for the preparation of oil-in-water emulsions useful in ophthalmic applications. In particular, processes are provided that include preparing a pre-concentrate of the oil-in-water emulsion, and diluting the pre-concentrate obtained to form the desired oil-in-water emulsion. The present invention also provides pharmaceutical compositions comprising an oil-in-water emulsion prepared by an inventive process, and methods of using these compositions for the treatment of an eye disease or condition.
Patent CA-2675957-A1 (CA)
Inventor: PACE CHARLES P
IPC: H04N7/24
Filed: 2008-01-04
Abstract: Personal object based archival systems and methods are provided for processing and compressing video. By analyzing features unique to a user, such as face, family, and pet attributes associated with the user, an invariant model can be determined to create object model adapters personal to each user. These personalized video object models can be created using geometric and appearance modeling techniques, and they can be stored in an object model library. The object models can be reused for processing other video streams. The object models can be shared in a peer-to-peer network among many users, or the object models can be stored in an object model library on a server. When the compressed (encoded) video is reconstructed, the video object models can be accessed and used to produce quality video with nearly lossless compression.
Patent CA-2677018-A1 (CA)
Inventor: PALMU LAURI
IPC: C25C7/02
Filed: 2008-02-13
Abstract: A method of manufacturing a cathode plate (1) that is used in the electrolytic cleaning and recovery of metals, the cathode plate being at least partly manufactured of stainless steel and the surface of the cathode plate being treated in at least one stage, whereby the cathode plate is formed by cutting it from a solid plate-like material (2), whereby, essentially before cutting (4) the cathode plate to shape, at least part of the surface constituting the cathode plate is subjected to a mechanical treatment (3) to improve the adhesion properties of the surface. The invention also relates to the cathode plate.
Patent CA-2677486-A1 (CA)
Inventor: LOWE KENNETH W
IPC: E21B43/12
Filed: 2009-09-02
Abstract: A gas flow system for removing a liquid from a well bore and allowing for gas production is provided. The gas flow system comprises a casing in the well bore for allowing flow of the liquid and gas; a tubing string in the casing for allowing flow of the liquid and gas; pressure measurement devices for use in determining a rate of liquid influx into the well bore; a casing control valve moveable between various positions ranging from fully open to fully closed for controlling flow through the casing; a tubing control valve moveable between various positions ranging from fully open to fully closed for controlling flow through the tubing; and flow measurement devices for determining the rate of flow through the tubing and the total rate of flow. The system is switchable between a current production phase and an alternate production phase based on the determined rate of liquid influx, a tubing critical velocity and a gas flow rate through the tubing, wherein switching from a current production phase to an alternate production phase results in the either or both of a decrease in liquid build-up in the well bore and an increase in gas production rate and wherein the current production phase differs from the alternate production phase.
Patent CA-2679511-A1 (CA)
Title: System and method for detection of hiv drug resistant variants
Inventor: SIMEN BIRGITTE BINDERUP
IPC: C12Q1/68
Filed: 2008-03-14
Abstract: In one embodiment of the invention a method for detecting low frequency occurrence of one or more HIV sequence variants associated with drug resistance is describe that comprises generating cDNA species from RNA molecules in an HIV sample population; amplifying first amplicons from the cDNA species, wherein each amplicon comprises amplified copies and is amplified with a pair of nucleic acid primers that define a locus; clonally amplifying the amplified copies of the first amplicons to produce second amplicons that comprise an immobilized population of substantially identical copies from one of the amplified copies of first amplicons; determining a nucleic acid sequence composition from at least 100 of the immobilized populations in parallel on a single instrument; detecting one or more sequence variants that occur at a frequency of 5% or less in the nucleic acid sequence composition of the at least 100 immobilized populations; and correlating the detected sequence variants with variation associated with HIV drug resistance.
Patent CA-2680595-A1 (CA)
Inventor: RECHID JULIAN
IPC: H01L31/0224
Filed: 2007-08-15
Abstract: The solar cell has at least one semiconductor layer arranged on a metal s upport and is provided with a plurality of contact tracks arranged on the se miconductor layer. A lateral projection by at least one contact track is ben t around onto a reverse of the support and arranged so as to be electrically insulated from the support. Adjacently arranged solar cells are preferably interconnected by conductor tracks which have a perforated form in order to allow local contact-connections by soldering through.
Patent CA-2680636-A1 (CA)
Inventor: HYND GEORGE
IPC: C07D215/22
Filed: 2007-03-29
Abstract: Specific quinoline derivatives are CRTH2 antagonists, useful in the treatment of conditions having an inflammatory component.
Patent CA-2681266-A1 (CA)
Inventor: BRUMMITT DALE
IPC: E01C23/03
Filed: 2009-09-30
Abstract: A heat transfer system having a flexible surface member having a first side and a second side, forming a heat transfer surface, and two or more thermal conduits, spaced apart and extending across a portion of the heat transfer surface, the two or more thermal conduits adapted to receive a thermal media to form a heat source (heating) or heat sink (cooling) across the heat transfer surface. The flexible surface member may have a plurality of edge regions, the two or more thermal conduits extending between edge regions, such as adjacent edge regions or opposing edge regions. The flexible surface member may have a plurality of corner regions, the two or more thermal conduits extending between corner regions, such as adjacent corner regions or opposing corner regions.
Patent CA-2682718-A1 (CA)
Title: High frequency oscillation respiratory therapy device
Inventor: WISE GEOFFREY C
IPC: A61M16/20
Filed: 2008-04-02
Abstract: A respiratory therapy device including a housing, a flow diverter structure, a high frequency pressure port (HF port), and an entrainment port. The housing defines a primary passageway having a patient interface side. The flow diverter structure is in fluid communication with the primary passageway and is characterized by the absence of a venturi tube. The HF port is configured for fluid connection to a source of oscillatory gas flow, and is fluidly associated with the flow diverter structure. The entrainment port is openable to ambient air, and is fluidly associated with the flow diverter structure. With this construction, the device is configured such that flow characteristics of gas flow from an external source are altered upon interacting with the flow diverter structure to create a pressure drop for drawing in ambient air through the entrainment port in delivering a percussive pressure therapy to the patient side.
Patent CA-2687427-A1 (CA)
Inventor: DUNNE COLUM
IPC: A23L33/00
Filed: 2008-05-02
Abstract: Use of whey protein isolate in the preparation of a composition for increasing mean aerobic capacity, enhanced hemoglobin production, enhanced red blood cell production and increased mean corpuscular hemoglobin concentration in competitive species, such as equine species, involved in strenuous activity. The composition may further comprise a prebiotic such as a fructo-oligosaccharide for example inulin.
Patent CA-2689730-A1 (CA)
Inventor: TAN XIQIAO
IPC: B05B1/22
Filed: 2010-01-12
Abstract: A bronze outlet pipe and making process thereof comprises the steps of: a. fluid inflation forming; b. working an outer wall of the tube member; c. working a first and a second connectors; d. working an arcuate leadless brass tube; e. selectively welding the first inlet with the orifice or welding the first outlet with the mouth together; f. welding the first connector and the tube member together; g. selectively welding the first connector or the second connector with the first opening of the first inlet together, or welding the orifice of the first connector or the mouth of the second connector with the first inlet of the tube member or the first outlet of the tube member together; h. surface treating; wherein the tube member and plural welding portions are surface treated to finish the bronze outlet pipe.
Patent CA-2690880-A1 (CA)
Inventor: GAREY HAROLD ELBRIDGE JR
IPC: C08G18/10
Filed: 2008-05-28
Abstract: The present invention provides novel antimicrobial polyurethane compositions having excellent mechanical and biocompatibility properties, and methods to prepare them. The antimicrobial polyurethane compositions include a homogenous distribution of silver ions by incorporating this antimicrobial agent into the composition prior to the complete polymerization of the polyurethane. In preferred embodiments, the silver ion is associated with a carrier, such as zirconium phosphate or soluble glass powder. The present invention also includes components made from the antimicrobial polyurethane compositions, such as medical devices.
Patent CA-2692423-A1 (CA)
Inventor: CYMBALSKI BRENT
IPC: B60N2/75
Filed: 2007-04-13
Abstract: The present invention provides a human form child car seat adapted to have a child seated therein,, the child car seat comprising: (a) a seat body having (i) a generally human body head and arm shape, including a seat wall and a backrest wall; (ii) a front seat side; (iii) a back side; (iv) a top side; (v) bottom side; (vi) a left side; and (vii) a right side; (b) a top side concave- shaped head support, the head support capable of cradling a juvenile head comprising (i) a left side head support and (ii) a right side head support; (c) a left arm rest having a generally human arm shape, the arm rest terminating in a cup holder having a generally human fist shape, the cup holder capable of receivably accepting a geometrically shaped object; (d) a right arm rest having a generally human arm shape, the arm rest terminating in a cup holder having a generally human fist shape the cup holder capable of receivably accepting a geometrically shaped object; and (e) a seat base. The present invention further provides a quick release seatbelt system, capable of rapidly disengaging the seatbelts, enabling rapid release of a child from the seat.     The present invention provides a human form child car seat adapted to have a child seated there in the child car seat comprising: a seat body having a generally human body head and arm shape; a top side concave-shaped head support, the head support capable of cradling a juvenile head, a left arm rest having a generally human arm shape, the arm rest terminating in a cup holder having a generally human fist shape; a right arm rest having a generally human arm shape, the arm rest terminating in a cup holder having a generally human fist shape; and a seat base. The present invention further provides a quick release seatbelt system, capable of rapidly disengaging the seatbelts, enabling rapid release of a child from the seat.
Patent CA-2692810-A1 (CA)
Inventor: WUBBELING MARTIN
IPC: A61F2/966
Filed: 2008-07-10
Abstract: There is disclosed herein a device (1) for moving an elongate member relative to an elongate body through which it extends, the device comprising: a housing (10) connectable to the elongate body; a mover (20) associated with the housing and connectable to the elongate member for moving the elongate member relative to the housing and relative to a connected elongate body; and a pre-mover (40) for adjusting an elongate member connected to the mover relative to an elongate body connected to the housing in preparation for moving the elongate member with the mover. There is also disclosed a related surgical apparatus.
Patent CA-2694423-A1 (CA)
Inventor: LEE JU HWAN
IPC: F16L11/08
Filed: 2010-02-23
Abstract: The present invention provides a spiral hose comprising:  a main body made of a soft synthetic resin material and wound in a spiral shape; and a reinforcing core having an elliptical sectional shape made of a hard synthetic resin material and embedded in a spiral shape into the main body so that the entire wall of the main body has a reduced thickness.
Patent CA-2700200-A1 (CA)
Inventor: BRODY JEROME S
IPC: G01N33/574
Filed: 2008-09-19
Abstract: The invention provides the identification of oncogenic pathways activated in cytologically normal airway cells of individuals having or at risk of having lung disease, as well as specific gene expression patterns (biomarkers) associated with pathway activation. These biomarkers and pathways may provide prognostic and/or diagnostic indicators in lung disease, e.g., lung cancer. Additionally, these pathways and biomarkers may provide therapeutic targets for the treatment of lung disease, as well as markers for the assessment of treatment efficacy.
Patent CA-2703140-A1 (CA)
Inventor: CIZEAU JEANNICK
IPC: G01N33/574
Filed: 2008-10-23
Abstract: The present application provides the amino acid and nucleic acid sequences of heavy and light chain complementarity determining regions of a cancer specific antibody directed to an epitope of variant Heterogeneous Ribonucleoprotein G  (HnRNPG). In addition, the application provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods of uses thereof. The application also relates to diagnostic methods and kits using the cancer specific antibodies disclosed herein. Further, the application provides novel cancer-associated epitopes and antigens of variant HnRNPG, and uses thereof.
Patent CA-2703364-A1 (CA)
Inventor: AOKI KEI ROGER
IPC: A61P29/00
Filed: 2008-10-21
Abstract: The present specification discloses modified Clostridial toxins, compositions comprising such toxins and methods of treating chronic neurogenic inflammation in a mammal using such modified Clostridial toxins and compositions.
Patent CA-2703741-A1 (CA)
Inventor: ZAMORA MARIO
IPC: E21B49/08
Filed: 2008-10-24
Abstract: A system for monitoring fluids at a drilling location, the system including a viscometer (210) having a heating cup and a pump (211) in clued communication with the heating cup, wherein the pump is configured to provide a flow of fluid from a fluid line inlet to the heating cup. The system also including a cleaning fluid tank (214) including communication with the heating cup, wherein the pump is configured to provide a flow of cleaning fluid from the cleaning fluid tank to the heating cup, and a system controller (217) configured to provide instructions to the pump for controlling the flow of cleaning fluid from the cleaning fluid tanks to the heating cup.
Patent CA-2705146-A1 (CA)
Inventor: HART KYLE
IPC: G06F19/00
Filed: 2008-11-06
Abstract: Described are novel quantification methods and systems that permit, within the context of multiplex PCR, the quantification of all targets within a single reaction tube. The methods employ quantitation algorithms applied to the amplification profiles of internal calibration controls or standards utilizing a plurality of nucleic acid templates that are amplified within the same reaction tube as the nucleic acid target(s) interrogated.
Patent CA-2706084-A1 (CA)
Title: Variable interleave data transmission
Inventor: GILSON ROSS O
IPC: H04J3/16
Filed: 2010-05-31
Abstract: In cable modem termination systems (CMTS) and other information transmission systems, a method for changing the interleave depth associated with each data stream is provided.  This may be done dynamically, and for any subset of downstream devices such as modems. The interleave depth may be set on an individual device level.  Embodiments may decrease data receiving latency on devices that do not suffer from error rates, such as caused by burst noise, while maintaining throughput on devices with high error rates.
Patent CA-2706583-A1 (CA)
Inventor: O'TOOLE JENNIFER
IPC: A61P35/00
Filed: 2008-11-21
Abstract: The invention provides antibodies or fragments thereof, including human antibodies, specific for Macrophage-Stimulating Protein Receptor (MSP-R or RON), which inhibit RON activation.  Also provided are methods to inhibit RON, particularly the use of RON antibodies to treat diseases such as cancer.
Patent CA-2706737-A1 (CA)
Title: A multi-reader, multi-writer lock-free ring buffer
Inventor: RUSHWORTH THOMAS BRYAN
IPC: G06F12/00
Filed: 2009-01-29
Abstract: Provided are a method and system for accessing cells of a ring buffer by one or more writers, a method and system for accessing cells of a ring buffer by one or more readers, and an improved multi-reader, multi-writer lock-free ring buffer. In general, the invention provides a method of providing lock-free access to a ring buffer by multiple readers and/or writers using only two local variables and a compare-and-swap ("CAS") operation.
Patent CA-2708616-A1 (CA)
Title: Rear-contact solar cell having extensive rear side emitter regions and method for producing the same
Inventor: HARDER NILS-PETER
IPC: H01L31/068
Filed: 2008-11-28
Abstract: The invention relates to a rear-contact solar cell and to a method for producing the same. The rear-contact solar cell comprises a semiconductor substrate (1) on the rear side surface (3) of which emitter regions (5), contacted by emitter contacts (11), and base regions (7), contacted by base contacts (13), are defined. The emitter regions and the base regions overlap at least in overlap regions (19), the emitter regions (5) in the overlap regions (19) reaching deeper into the semiconductor substrate (1) than the base regions (7), when seen from the rear side surface of the solar cell. As a result, a large area percentage of the rear side of the semiconductor substrate can be covered with a charge-collecting emitter, said emitter being at least partially buried in the interior of the semiconductor substrate (1) so that there is no risk of the base contacts (13) provoking a short circuit towards the buried emitter regions (5).
Patent CA-2709823-A1 (CA)
Inventor: MATTSSON KARIN
IPC: G01N33/68
Filed: 2008-12-18
Abstract: The invention relates to process for in vitro prediction of a potentially allergenic substance wherein monocytes and/or macrophages and/or myelomonocytic cell lines are cultivated in the presence of the substance and interferon-.gamma., whereby productions of cytokines and/or neopterin are increased and measured. The allergic reaction may be estimated by measuring up regulated or down- regulated genes chosen from G 1P2, OASL, IFIT1, TRIM22, IFI44L, MXI, RSAD2, IFIT3, IFITM 1, IFIT2, C 33.28 HERV-H protein mRNA, IFITM3, XK, GPR15, MT1 G, MT1B;MT1A, ADFP, IL8, MT1 E, MT1F, MT1 H, SLC30A 1, SERPINB2, CD83, TncRNA or expression products from them are measured. The invention also relates to a reagent kit for use in the process comprising interferon-.gamma. and reagents which recognise cytokines preferably each of IL-8 and neopterin and /or reagents such as probes recognising up-regulated or down- regulated genes.